Address And Details

4500 Main St. , Kansas City, MO 64111
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund seeks long-term capital growth. Income is a secondary objective. Under normal market conditions, the portfolio managers will invest at least 80% of the fund s net assets in medium size companies. The portfolio managers consider medium size companies to include those whose market capitalizations at the time of purchase are within the capitalization range of the Russell 3000 Index, excluding the largest 100 such companies. The portfolio managers intend to manage the fund so that its weighted capitalization falls within the capitalization range of the members of the Russell Midcap Index. Though market capitalization may change from time to time, as of June 30, 2020, the capitalization ranges of the Russell 3000 Index, excluding the largest 100 companies, and the Russell Midcap Index were $41.0 million to $60.3 billion and $557.0 million to $48.0 billion, respectively. In selecting stocks for the fund, the portfolio managers look for companies whose stock price may not reflect the company s value. The managers attempt to purchase the stocks of these undervalued companies and hold each stock until the price has increased to, or is higher than, a level the managers believe more accurately reflects the fair value of the company. The fund may invest a portion of its assets in foreign securities when these securities meet the portfolio managers standards of selection. The portfolio managers may sell stocks from the fund s portfolio if they believe a stock no longer meets their valuation criteria, a stock s risk parameters outweigh its return opportunity, more attractive alternatives are identified or specific events alter a stock s prospects.

Net Asset Value

as of 5:26 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.10%
  • 1 Month
  • -1.87%
  • 3 Months
  • -0.51%
  • 1 Yr Return
  • +28.75%
  • 5 Yr Return
  • +20.36%

Equity Sector Breakdown

Finance 22.73%
IndustrialCyclical 17.53%
RetailTrade 11.85%
NonDurables 8.73%
Health 8.42%
Technology 8.29%
Utilities 7.65%
ConsumerDurables 4.50%
Energy 3.77%
Services 1.83%

Asset Allocation

Asset Type % Of Allocation
Stocks 98.68%
ForeignStocks 11.42%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 100.99 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -8.67 -7.62 -3.16
Beta 1.06 1.05 0.98
R Squared 0.89 0.87 0.87
Std Deviation 20.91 16.86 14.14
Sharpe Ratio 0.47 0.59 n/a

Purchase Information

as of 5:26 PM ET 09/16/2021
Minimum Initial $2500
Minimum Additional $50
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +33.36%
  • +39.82%
+33.36% +39.82%
3 Year
  • +8.41%
  • +9.41%
+8.41% +9.41%
10 Year
  • +12.18%
  • +11.03%
+12.18% +11.03%
Life Of Fund
  • +9.17%
  • +9.15%
+9.17% +9.15%

Top 10 Holdings

Symbol Company Name % Of Assets
ZBH ZIMMER BIOMET HOLDINGS INC 3.02%
BK BANK OF NEW YORK MELLON CORP 2.54%
NTRS NORTHERN TRUST CORP 2.19%
EMR EMERSON ELECTRIC CO 2.10%
CB CHUBB LTD 2.01%
AAP ADVANCE AUTO PARTS 1.98%
CAG CONAGRA BRANDS INC 1.93%
CERN CERNER CORP 1.91%
DGX QUEST DIAGNOSTICS INC 1.90%
UHS UNIVERSAL HEALTH SERVICES INC 1.89%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.